APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Spermicides

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Spermicides Market Analysis and Forecast 2026-2032

Report ID 174037320230 December 2025193 pages

Choose your research edition.

Industry ResearchSpermicides Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Spermicides Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Spermicides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spermicides Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Spermicides Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Spermicides market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Spermicides is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Spermicides is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Spermicides is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Spermicides is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Spermicides include Advantage-S, Conceptrol, Crinone, Delfen Foam, Emko, Encare, Endometrin, First-Progesterone VGS and Gynol II, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Spermicides, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Spermicides, also provides the sales of main regions and countries. Of the upcoming market potential for Spermicides, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Spermicides sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Spermicides market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Spermicides sales, projected growth trends, production technology, application and end-user industry.

Spermicides Segment by Company

Advantage-S

Conceptrol

Crinone

Delfen Foam

Emko

Encare

Endometrin

First-Progesterone VGS

Gynol II

Phexxi

Prochieve

Spermicides Segment by Type

Suppositories

Creams

Foams

Gels

Film

Spermicides Segment by Application

Online Pharmacies

Retail Pharmacies

Hospital

Spermicides Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spermicides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spermicides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spermicides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Spermicides in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Spermicides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spermicides sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Spermicides Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Suppositories Major Manufacturers Table 3. Creams Major Manufacturers Table 4. Foams Major Manufacturers Table 5. Gels Major Manufacturers Table 6. Film Major Manufacturers Table 7. Global Spermicides Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Online Pharmacies Major Manufacturers Table 9. Retail Pharmacies Major Manufacturers Table 10. Hospital Major Manufacturers Table 11. Spermicides Industry Trends Table 12. Spermicides Industry Drivers Table 13. Spermicides Industry Opportunities and Challenges Table 14. Spermicides Industry Restraints Table 15. Global Spermicides Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Spermicides Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Spermicides Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Spermicides Revenue Market Share by Region (2021-2026) Table 19. Global Spermicides Revenue Market Share by Region (2027-2032) Table 20. Global Spermicides Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Spermicides Sales by Region (2021-2026) & (K Units) Table 22. Global Spermicides Sales by Region (2027-2032) & (K Units) Table 23. Global Spermicides Sales Market Share by Region (2021-2026) Table 24. Global Spermicides Sales Market Share by Region (2027-2032) Table 25. Global Spermicides Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Spermicides Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Spermicides Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Spermicides Sales Market Share by Manufacturers (2021-2026) Table 29. Global Spermicides Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Spermicides Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Spermicides Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Spermicides Manufacturers, Product Type & Application Table 33. Global Spermicides Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Spermicides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Spermicides Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Spermicides Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Spermicides Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Spermicides Revenue Market Share by Type (2021-2026) Table 40. Global Spermicides Revenue Market Share by Type (2027-2032) Table 41. Global Spermicides Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Spermicides Sales by Type (2021-2026) & (K Units) Table 43. Global Spermicides Sales by Type (2027-2032) & (K Units) Table 44. Global Spermicides Sales Market Share by Type (2021-2026) Table 45. Global Spermicides Sales Market Share by Type (2027-2032) Table 46. Global Spermicides Price by Type (2021-2026) & (US$/Unit) Table 47. Global Spermicides Price by Type (2027-2032) & (US$/Unit) Table 48. Global Spermicides Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Spermicides Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Spermicides Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Spermicides Revenue Market Share by Application (2021-2026) Table 52. Global Spermicides Revenue Market Share by Application (2027-2032) Table 53. Global Spermicides Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Spermicides Sales by Application (2021-2026) & (K Units) Table 55. Global Spermicides Sales by Application (2027-2032) & (K Units) Table 56. Global Spermicides Sales Market Share by Application (2021-2026) Table 57. Global Spermicides Sales Market Share by Application (2027-2032) Table 58. Global Spermicides Price by Application (2021-2026) & (US$/Unit) Table 59. Global Spermicides Price by Application (2027-2032) & (US$/Unit) Table 60. Advantage-S Company Information Table 61. Advantage-S Business Overview Table 62. Advantage-S Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Advantage-S Spermicides Product Portfolio Table 64. Advantage-S Recent Development Table 65. Conceptrol Company Information Table 66. Conceptrol Business Overview Table 67. Conceptrol Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Conceptrol Spermicides Product Portfolio Table 69. Conceptrol Recent Development Table 70. Crinone Company Information Table 71. Crinone Business Overview Table 72. Crinone Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Crinone Spermicides Product Portfolio Table 74. Crinone Recent Development Table 75. Delfen Foam Company Information Table 76. Delfen Foam Business Overview Table 77. Delfen Foam Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Delfen Foam Spermicides Product Portfolio Table 79. Delfen Foam Recent Development Table 80. Emko Company Information Table 81. Emko Business Overview Table 82. Emko Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Emko Spermicides Product Portfolio Table 84. Emko Recent Development Table 85. Encare Company Information Table 86. Encare Business Overview Table 87. Encare Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Encare Spermicides Product Portfolio Table 89. Encare Recent Development Table 90. Endometrin Company Information Table 91. Endometrin Business Overview Table 92. Endometrin Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Endometrin Spermicides Product Portfolio Table 94. Endometrin Recent Development Table 95. First-Progesterone VGS Company Information Table 96. First-Progesterone VGS Business Overview Table 97. First-Progesterone VGS Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. First-Progesterone VGS Spermicides Product Portfolio Table 99. First-Progesterone VGS Recent Development Table 100. Gynol II Company Information Table 101. Gynol II Business Overview Table 102. Gynol II Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Gynol II Spermicides Product Portfolio Table 104. Gynol II Recent Development Table 105. Phexxi Company Information Table 106. Phexxi Business Overview Table 107. Phexxi Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Phexxi Spermicides Product Portfolio Table 109. Phexxi Recent Development Table 110. Prochieve Company Information Table 111. Prochieve Business Overview Table 112. Prochieve Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Prochieve Spermicides Product Portfolio Table 114. Prochieve Recent Development Table 115. North America Spermicides Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Spermicides Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Spermicides Sales by Type (2021-2026) & (K Units) Table 118. North America Spermicides Sales by Type (2027-2032) & (K Units) Table 119. North America Spermicides Sales Price by Type (2021-2026) & (US$/Unit) Table 120. North America Spermicides Sales Price by Type (2027-2032) & (US$/Unit) Table 121. North America Spermicides Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Spermicides Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Spermicides Sales by Application (2021-2026) & (K Units) Table 124. North America Spermicides Sales by Application (2027-2032) & (K Units) Table 125. North America Spermicides Sales Price by Application (2021-2026) & (US$/Unit) Table 126. North America Spermicides Sales Price by Application (2027-2032) & (US$/Unit) Table 127. North America Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Spermicides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. North America Spermicides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. North America Spermicides Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. North America Spermicides Sales by Country (2021-2026) & (K Units) Table 132. North America Spermicides Sales by Country (2027-2032) & (K Units) Table 133. North America Spermicides Sales Price by Country (2021-2026) & (US$/Unit) Table 134. North America Spermicides Sales Price by Country (2027-2032) & (US$/Unit) Table 135. United States Spermicides Revenue (2021-2032) & (US$ Million) Table 136. Canada Spermicides Revenue (2021-2032) & (US$ Million) Table 137. Europe Spermicides Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Spermicides Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Spermicides Sales by Type (2021-2026) & (K Units) Table 140. Europe Spermicides Sales by Type (2027-2032) & (K Units) Table 141. Europe Spermicides Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Europe Spermicides Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Europe Spermicides Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Spermicides Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Spermicides Sales by Application (2021-2026) & (K Units) Table 146. Europe Spermicides Sales by Application (2027-2032) & (K Units) Table 147. Europe Spermicides Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Europe Spermicides Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Europe Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Spermicides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Europe Spermicides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Europe Spermicides Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Europe Spermicides Sales by Country (2021-2026) & (K Units) Table 154. Europe Spermicides Sales by Country (2027-2032) & (K Units) Table 155. Europe Spermicides Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Europe Spermicides Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Germany Spermicides Revenue (2021-2032) & (US$ Million) Table 158. France Spermicides Revenue (2021-2032) & (US$ Million) Table 159. U.K. Spermicides Revenue (2021-2032) & (US$ Million) Table 160. Italy Spermicides Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Spermicides Revenue (2021-2032) & (US$ Million) Table 162. China Spermicides Revenue by Type (2021-2026) & (US$ Million) Table 163. China Spermicides Revenue by Type (2027-2032) & (US$ Million) Table 164. China Spermicides Sales by Type (2021-2026) & (K Units) Table 165. China Spermicides Sales by Type (2027-2032) & (K Units) Table 166. China Spermicides Sales Price by Type (2021-2026) & (US$/Unit) Table 167. China Spermicides Sales Price by Type (2027-2032) & (US$/Unit) Table 168. China Spermicides Revenue by Application (2021-2026) & (US$ Million) Table 169. China Spermicides Revenue by Application (2027-2032) & (US$ Million) Table 170. China Spermicides Sales by Application (2021-2026) & (K Units) Table 171. China Spermicides Sales by Application (2027-2032) & (K Units) Table 172. China Spermicides Sales Price by Application (2021-2026) & (US$/Unit) Table 173. China Spermicides Sales Price by Application (2027-2032) & (US$/Unit) Table 174. Asia Spermicides Revenue by Type (2021-2026) & (US$ Million) Table 175. Asia Spermicides Revenue by Type (2027-2032) & (US$ Million) Table 176. Asia Spermicides Sales by Type (2021-2026) & (K Units) Table 177. Asia Spermicides Sales by Type (2027-2032) & (K Units) Table 178. Asia Spermicides Sales Price by Type (2021-2026) & (US$/Unit) Table 179. Asia Spermicides Sales Price by Type (2027-2032) & (US$/Unit) Table 180. Asia Spermicides Revenue by Application (2021-2026) & (US$ Million) Table 181. Asia Spermicides Revenue by Application (2027-2032) & (US$ Million) Table 182. Asia Spermicides Sales by Application (2021-2026) & (K Units) Table 183. Asia Spermicides Sales by Application (2027-2032) & (K Units) Table 184. Asia Spermicides Sales Price by Application (2021-2026) & (US$/Unit) Table 185. Asia Spermicides Sales Price by Application (2027-2032) & (US$/Unit) Table 186. Asia Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Asia Spermicides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Asia Spermicides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Asia Spermicides Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 190. Asia Spermicides Sales by Country (2021-2026) & (K Units) Table 191. Asia Spermicides Sales by Country (2027-2032) & (K Units) Table 192. Asia Spermicides Sales Price by Country (2021-2026) & (US$/Unit) Table 193. Asia Spermicides Sales Price by Country (2027-2032) & (US$/Unit) Table 194. Japan Spermicides Revenue (2021-2032) & (US$ Million) Table 195. South Korea Spermicides Revenue (2021-2032) & (US$ Million) Table 196. India Spermicides Revenue (2021-2032) & (US$ Million) Table 197. Australia Spermicides Revenue (2021-2032) & (US$ Million) Table 198. China Taiwan Spermicides Revenue (2021-2032) & (US$ Million) Table 199. Southeast Asia Spermicides Revenue (2021-2032) & (US$ Million) Table 200. SAMEA Spermicides Revenue by Type (2021-2026) & (US$ Million) Table 201. SAMEA Spermicides Revenue by Type (2027-2032) & (US$ Million) Table 202. SAMEA Spermicides Sales by Type (2021-2026) & (K Units) Table 203. SAMEA Spermicides Sales by Type (2027-2032) & (K Units) Table 204. SAMEA Spermicides Sales Price by Type (2021-2026) & (US$/Unit) Table 205. SAMEA Spermicides Sales Price by Type (2027-2032) & (US$/Unit) Table 206. SAMEA Spermicides Revenue by Application (2021-2026) & (US$ Million) Table 207. SAMEA Spermicides Revenue by Application (2027-2032) & (US$ Million) Table 208. SAMEA Spermicides Sales by Application (2021-2026) & (K Units) Table 209. SAMEA Spermicides Sales by Application (2027-2032) & (K Units) Table 210. SAMEA Spermicides Sales Price by Application (2021-2026) & (US$/Unit) Table 211. SAMEA Spermicides Sales Price by Application (2027-2032) & (US$/Unit) Table 212. SAMEA Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. SAMEA Spermicides Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. SAMEA Spermicides Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. SAMEA Spermicides Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. SAMEA Spermicides Sales by Country (2021-2026) & (K Units) Table 217. SAMEA Spermicides Sales by Country (2027-2032) & (K Units) Table 218. SAMEA Spermicides Sales Price by Country (2021-2026) & (US$/Unit) Table 219. SAMEA Spermicides Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Brazil Spermicides Revenue (2021-2032) & (US$ Million) Table 221. Argentina Spermicides Revenue (2021-2032) & (US$ Million) Table 222. Chile Spermicides Revenue (2021-2032) & (US$ Million) Table 223. Colombia Spermicides Revenue (2021-2032) & (US$ Million) Table 224. Peru Spermicides Revenue (2021-2032) & (US$ Million) Table 225. Saudi Arabia Spermicides Revenue (2021-2032) & (US$ Million) Table 226. Israel Spermicides Revenue (2021-2032) & (US$ Million) Table 227. UAE Spermicides Revenue (2021-2032) & (US$ Million) Table 228. Turkey Spermicides Revenue (2021-2032) & (US$ Million) Table 229. Iran Spermicides Revenue (2021-2032) & (US$ Million) Table 230. Egypt Spermicides Revenue (2021-2032) & (US$ Million) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Spermicides Distributors List Table 234. Spermicides Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Spermicides Image Figure 2. Global Spermicides Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spermicides Market Size Share 2021 VS 2025 VS 2032 Figure 4. Suppositories Image Figure 5. Creams Image Figure 6. Foams Image Figure 7. Gels Image Figure 8. Film Image Figure 9. Global Spermicides Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Spermicides Market Size Share 2021 VS 2025 VS 2032 Figure 11. Online Pharmacies Image Figure 12. Retail Pharmacies Image Figure 13. Hospital Image Figure 14. Global Spermicides Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Spermicides Revenue (2021-2032) & (US$ Million) Figure 16. Global Spermicides Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Spermicides Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Spermicides Revenue Market Share by Region (2021-2032) Figure 19. Global Spermicides Sales (2021-2032) & (K Units) Figure 20. Global Spermicides Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Spermicides Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Spermicides Sales YoY (2021-2032) & (K Units) Figure 23. Europe Spermicides Sales YoY (2021-2032) & (K Units) Figure 24. China Spermicides Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Spermicides Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Spermicides Sales YoY (2021-2032) & (K Units) Figure 27. Global Spermicides Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Spermicides Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Spermicides Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Spermicides Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Spermicides Revenue Market Share by Type (2021-2032) Figure 33. Global Spermicides Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Spermicides Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Spermicides Sales Market Share by Type (2021-2032) Figure 36. Global Spermicides Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Spermicides Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Spermicides Revenue Market Share by Application (2021-2032) Figure 39. Global Spermicides Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Spermicides Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Spermicides Sales Market Share by Application (2021-2032) Figure 42. North America Spermicides Revenue Share by Type (2021-2032) Figure 43. North America Spermicides Sales Share by Type (2021-2032) Figure 44. North America Spermicides Revenue Share by Application (2021-2032) Figure 45. North America Spermicides Sales Share by Application (2021-2032) Figure 46. North America Spermicides Revenue Share by Country (2021-2032) Figure 47. North America Spermicides Sales Share by Country (2021-2032) Figure 48. Europe Spermicides Revenue Share by Type (2021-2032) Figure 49. Europe Spermicides Sales Share by Type (2021-2032) Figure 50. Europe Spermicides Revenue Share by Application (2021-2032) Figure 51. Europe Spermicides Sales Share by Application (2021-2032) Figure 52. Europe Spermicides Revenue Share by Country (2021-2032) Figure 53. Europe Spermicides Sales Share by Country (2021-2032) Figure 54. China Spermicides Revenue Share by Type (2021-2032) Figure 55. China Spermicides Sales Share by Type (2021-2032) Figure 56. China Spermicides Revenue Share by Application (2021-2032) Figure 57. China Spermicides Sales Share by Application (2021-2032) Figure 58. Asia Spermicides Revenue Share by Type (2021-2032) Figure 59. Asia Spermicides Sales Share by Type (2021-2032) Figure 60. Asia Spermicides Revenue Share by Application (2021-2032) Figure 61. Asia Spermicides Sales Share by Application (2021-2032) Figure 62. Asia Spermicides Revenue Share by Country (2021-2032) Figure 63. Asia Spermicides Sales Share by Country (2021-2032) Figure 64. SAMEA Spermicides Revenue Share by Type (2021-2032) Figure 65. SAMEA Spermicides Sales Share by Type (2021-2032) Figure 66. SAMEA Spermicides Revenue Share by Application (2021-2032) Figure 67. SAMEA Spermicides Sales Share by Application (2021-2032) Figure 68. SAMEA Spermicides Revenue Share by Country (2021-2032) Figure 69. SAMEA Spermicides Sales Share by Country (2021-2032) Figure 70. Spermicides Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Spermicides Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Suppositories
  • Creams
  • Foams
  • Gels
  • Film
Applications
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital
Companies covered
  • Advantage-S
  • Conceptrol
  • Crinone
  • Delfen Foam
  • Emko
  • Encare
  • Endometrin
  • First-Progesterone VGS
  • Gynol II
  • Phexxi
  • Prochieve

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Spermicides Market by Type
  3. 1.2.1 Global Spermicides Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Suppositories
  5. 1.2.3 Creams
  6. 1.2.4 Foams
  7. 1.2.5 Gels
  8. 1.2.6 Film
  9. 1.3 Spermicides Market by Application
  10. 1.3.1 Global Spermicides Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Online Pharmacies
  12. 1.3.3 Retail Pharmacies
  13. 1.3.4 Hospital
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Spermicides Market Dynamics
  1. 2.1 Spermicides Industry Trends
  2. 2.2 Spermicides Industry Drivers
  3. 2.3 Spermicides Industry Opportunities and Challenges
  4. 2.4 Spermicides Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Spermicides Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Spermicides Revenue by Region
  3. 3.2.1 Global Spermicides Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Spermicides Revenue by Region (2021-2026)
  5. 3.2.3 Global Spermicides Revenue by Region (2027-2032)
  6. 3.2.4 Global Spermicides Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Spermicides Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Spermicides Sales by Region
  9. 3.4.1 Global Spermicides Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Spermicides Sales by Region (2021-2026)
  11. 3.4.3 Global Spermicides Sales by Region (2027-2032)
  12. 3.4.4 Global Spermicides Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Spermicides Revenue by Manufacturers
  2. 4.1.1 Global Spermicides Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Spermicides Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Spermicides Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Spermicides Sales by Manufacturers
  6. 4.2.1 Global Spermicides Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Spermicides Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Spermicides Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Spermicides Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Spermicides Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Spermicides Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Spermicides Manufacturers, Product Type & Application
  13. 4.7 Global Spermicides Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Spermicides Market CR5 and HHI
  16. 4.8.2 2025 Spermicides Tier 1, Tier 2, and Tier 3
5 Spermicides Market by Type
  1. 5.1 Global Spermicides Revenue by Type
  2. 5.1.1 Global Spermicides Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Spermicides Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Spermicides Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Spermicides Sales by Type
  6. 5.2.1 Global Spermicides Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Spermicides Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Spermicides Sales Market Share by Type (2021-2032)
  9. 5.3 Global Spermicides Price by Type
6 Spermicides Market by Application
  1. 6.1 Global Spermicides Revenue by Application
  2. 6.1.1 Global Spermicides Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Spermicides Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Spermicides Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Spermicides Sales by Application
  6. 6.2.1 Global Spermicides Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Spermicides Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Spermicides Sales Market Share by Application (2021-2032)
  9. 6.3 Global Spermicides Price by Application
7 Company Profiles
  1. 7.1 Advantage-S
  2. 7.1.1 Advantage-S Company Information
  3. 7.1.2 Advantage-S Business Overview
  4. 7.1.3 Advantage-S Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Advantage-S Spermicides Product Portfolio
  6. 7.1.5 Advantage-S Recent Developments
  7. 7.2 Conceptrol
  8. 7.2.1 Conceptrol Company Information
  9. 7.2.2 Conceptrol Business Overview
  10. 7.2.3 Conceptrol Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Conceptrol Spermicides Product Portfolio
  12. 7.2.5 Conceptrol Recent Developments
  13. 7.3 Crinone
  14. 7.3.1 Crinone Company Information
  15. 7.3.2 Crinone Business Overview
  16. 7.3.3 Crinone Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Crinone Spermicides Product Portfolio
  18. 7.3.5 Crinone Recent Developments
  19. 7.4 Delfen Foam
  20. 7.4.1 Delfen Foam Company Information
  21. 7.4.2 Delfen Foam Business Overview
  22. 7.4.3 Delfen Foam Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Delfen Foam Spermicides Product Portfolio
  24. 7.4.5 Delfen Foam Recent Developments
  25. 7.5 Emko
  26. 7.5.1 Emko Company Information
  27. 7.5.2 Emko Business Overview
  28. 7.5.3 Emko Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Emko Spermicides Product Portfolio
  30. 7.5.5 Emko Recent Developments
  31. 7.6 Encare
  32. 7.6.1 Encare Company Information
  33. 7.6.2 Encare Business Overview
  34. 7.6.3 Encare Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Encare Spermicides Product Portfolio
  36. 7.6.5 Encare Recent Developments
  37. 7.7 Endometrin
  38. 7.7.1 Endometrin Company Information
  39. 7.7.2 Endometrin Business Overview
  40. 7.7.3 Endometrin Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Endometrin Spermicides Product Portfolio
  42. 7.7.5 Endometrin Recent Developments
  43. 7.8 First-Progesterone VGS
  44. 7.8.1 First-Progesterone VGS Company Information
  45. 7.8.2 First-Progesterone VGS Business Overview
  46. 7.8.3 First-Progesterone VGS Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 First-Progesterone VGS Spermicides Product Portfolio
  48. 7.8.5 First-Progesterone VGS Recent Developments
  49. 7.9 Gynol II
  50. 7.9.1 Gynol II Company Information
  51. 7.9.2 Gynol II Business Overview
  52. 7.9.3 Gynol II Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Gynol II Spermicides Product Portfolio
  54. 7.9.5 Gynol II Recent Developments
  55. 7.10 Phexxi
  56. 7.10.1 Phexxi Company Information
  57. 7.10.2 Phexxi Business Overview
  58. 7.10.3 Phexxi Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Phexxi Spermicides Product Portfolio
  60. 7.10.5 Phexxi Recent Developments
  61. 7.11 Prochieve
  62. 7.11.1 Prochieve Company Information
  63. 7.11.2 Prochieve Business Overview
  64. 7.11.3 Prochieve Spermicides Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Prochieve Spermicides Product Portfolio
  66. 7.11.5 Prochieve Recent Developments
8 North America
  1. 8.1 North America Spermicides Market Size by Type
  2. 8.1.1 North America Spermicides Revenue by Type (2021-2032)
  3. 8.1.2 North America Spermicides Sales by Type (2021-2032)
  4. 8.1.3 North America Spermicides Price by Type (2021-2032)
  5. 8.2 North America Spermicides Market Size by Application
  6. 8.2.1 North America Spermicides Revenue by Application (2021-2032)
  7. 8.2.2 North America Spermicides Sales by Application (2021-2032)
  8. 8.2.3 North America Spermicides Price by Application (2021-2032)
  9. 8.3 North America Spermicides Market Size by Country
  10. 8.3.1 North America Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Spermicides Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Spermicides Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Spermicides Market Size by Type
  2. 9.1.1 Europe Spermicides Revenue by Type (2021-2032)
  3. 9.1.2 Europe Spermicides Sales by Type (2021-2032)
  4. 9.1.3 Europe Spermicides Price by Type (2021-2032)
  5. 9.2 Europe Spermicides Market Size by Application
  6. 9.2.1 Europe Spermicides Revenue by Application (2021-2032)
  7. 9.2.2 Europe Spermicides Sales by Application (2021-2032)
  8. 9.2.3 Europe Spermicides Price by Application (2021-2032)
  9. 9.3 Europe Spermicides Market Size by Country
  10. 9.3.1 Europe Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Spermicides Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Spermicides Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Spermicides Market Size by Type
  2. 10.1.1 China Spermicides Revenue by Type (2021-2032)
  3. 10.1.2 China Spermicides Sales by Type (2021-2032)
  4. 10.1.3 China Spermicides Price by Type (2021-2032)
  5. 10.2 China Spermicides Market Size by Application
  6. 10.2.1 China Spermicides Revenue by Application (2021-2032)
  7. 10.2.2 China Spermicides Sales by Application (2021-2032)
  8. 10.2.3 China Spermicides Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Spermicides Market Size by Type
  2. 11.1.1 Asia Spermicides Revenue by Type (2021-2032)
  3. 11.1.2 Asia Spermicides Sales by Type (2021-2032)
  4. 11.1.3 Asia Spermicides Price by Type (2021-2032)
  5. 11.2 Asia Spermicides Market Size by Application
  6. 11.2.1 Asia Spermicides Revenue by Application (2021-2032)
  7. 11.2.2 Asia Spermicides Sales by Application (2021-2032)
  8. 11.2.3 Asia Spermicides Price by Application (2021-2032)
  9. 11.3 Asia Spermicides Market Size by Country
  10. 11.3.1 Asia Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Spermicides Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Spermicides Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Spermicides Market Size by Type
  2. 12.1.1 SAMEA Spermicides Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Spermicides Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Spermicides Price by Type (2021-2032)
  5. 12.2 SAMEA Spermicides Market Size by Application
  6. 12.2.1 SAMEA Spermicides Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Spermicides Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Spermicides Price by Application (2021-2032)
  9. 12.3 SAMEA Spermicides Market Size by Country
  10. 12.3.1 SAMEA Spermicides Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Spermicides Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Spermicides Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Spermicides Value Chain Analysis
  2. 13.1.1 Spermicides Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Spermicides Production Mode & Process
  6. 13.2 Spermicides Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Spermicides Distributors
  9. 13.2.3 Spermicides Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst